相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。TAZ Is a Negative Regulator of PPARγ Activity in Adipocytes and TAZ Deletion Improves Insulin Sensitivity and Glucose Tolerance
Dalila El Ouarrat et al.
CELL METABOLISM (2020)
TAZ couples Hippo/Wnt signalling and insulin sensitivity through Irs1 expression
Jun-Ha Hwang et al.
NATURE COMMUNICATIONS (2019)
The N-terminal phosphodegron targets TAZ/WWTR1 protein for SCF-TrCP-dependent degradation in response to phosphatidylinositol 3-kinase inhibition (vol 287, pg 26245, 2012)
Wei Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell
Steven W. Plouffe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Hippo-mediated suppression of IRS2/AKT signaling prevents hepatic steatosis and liver cancer
Sun-Hye Jeong et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Insulin signaling and reduced glucocorticoid receptor activity attenuate postprandial gene expression in liver
Adrija Kalvisa et al.
PLOS BIOLOGY (2018)
Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis
Sachin H. Patel et al.
GASTROENTEROLOGY (2017)
YAP Suppresses Gluconeogenic Gene Expression Through PGC1α
Yue Hu et al.
HEPATOLOGY (2017)
Single-cell spatial reconstruction reveals global division of labour in the mammalian liver (vol 542, pg 352, 2017)
Keren Bahar Halpern et al.
NATURE (2017)
mTOR Signaling in Growth, Metabolism, and Disease
Robert A. Saxton et al.
CELL (2017)
Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis
Xiaobo Wang et al.
CELL METABOLISM (2016)
Hepatic Glucocorticoid Receptor Plays a Greater Role Than Adipose GR in Metabolic Syndrome Despite Renal Compensation
Sandip K. Bose et al.
ENDOCRINOLOGY (2016)
Transcriptional and Chromatin Regulation during Fasting - The Genomic Era
Ida Goldstein et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)
Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis
Ji Miao et al.
NATURE COMMUNICATIONS (2015)
Hippo Pathway Activity Influences Liver Cell Fate
Dean Yimlamai et al.
CELL (2014)
Minireview: New Molecular Mediators of Glucocorticoid Receptor Activity in Metabolic Tissues
Rucha Patel et al.
MOLECULAR ENDOCRINOLOGY (2014)
THE BIOLOGY OF YAP/TAZ: HIPPO SIGNALING AND BEYOND
Stefano Piccolo et al.
PHYSIOLOGICAL REVIEWS (2014)
Prevalence of oral glucocorticoid usage in the United States: A general population perspective
Robert A. Overman et al.
ARTHRITIS CARE & RESEARCH (2013)
Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas
Elodie Mutel et al.
JOURNAL OF HEPATOLOGY (2011)
Role of YAP/TAZ in mechanotransduction
Sirio Dupont et al.
NATURE (2011)
TEAD Transcription Factors Mediate the Function of TAZ in Cell Growth and Epithelial-Mesenchymal Transition
Heng Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
DNA Binding Site Sequence Directs Glucocorticoid Receptor Structure and Activity
Sebastiaan H. Meijsing et al.
SCIENCE (2009)
Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling
Mitsunori Ota et al.
DEVELOPMENT (2008)
TEAD mediates YAP-dependent gene induction and growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2008)
TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway
Qun-Ying Lei et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Yap1 phosphorylation by c-AbI is a critical step in selective activation of proapoptotic genes in response to DNA damage
Dan Levy et al.
MOLECULAR CELL (2008)
PML, YAP, and p73 Are Components of a Proapoptotic Autoregulatory Feedback Loop
Eleonora Lapi et al.
MOLECULAR CELL (2008)
Multiple renal cysts, urinary concentration defects, and pulmonary emphysematous changes in mice lacking TAZ
Ryosuke Makita et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Glucocorticoid receptor physiology
Marjet D. Heitzer et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2007)
Glucocorticoids, metabolism and metabolic diseases
Alexandros Vegiopoulos et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2007)
A protocol for rapid generation of recombinant adenoviruses using the AdEasy system
Jinyong Luo et al.
NATURE PROTOCOLS (2007)
Functional inhibitory cross-talk between constitutive androstane receptor and hepatic nuclear factor-4 in hepatic lipid/glucose metabolism is mediated by competition for binding to the DR1 motif and to the common coactivators, GRIP-1 and PGC-1α
Ji Miao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth
XC Dong et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Defects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation in mice with targeted disruption of Yap65
EM Morin-Kensicki et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome
M Murakami et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The glucose-6-phosphatase catalytic subunit gene promoter contains both positive and negative glucocorticoid response elements
BT Vander Kooi et al.
MOLECULAR ENDOCRINOLOGY (2005)
TAZ, a transcriptional modulator of mesenchymal stem cell differentiation
JH Hong et al.
SCIENCE (2005)
Hepatic glucocorticoid receptor antagonism is sufficient to reduce elevated hepatic glucose output and improve glucose control in animal models of type 2 diabetes
PB Jacobson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
The search for safer glucocorticoid receptor ligands
J Rosen et al.
ENDOCRINE REVIEWS (2005)
Inactivation of the glucocorticoid receptor in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia in streptozotocin-induced diabetes mellitus
C Opherk et al.
MOLECULAR ENDOCRINOLOGY (2004)
WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus
A Komuro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
RU486-induced glucocorticoid receptor agonism is controlled by the receptor N terminus and by corepressor binding
M Schulz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor
HM Reichardt et al.
EMBO JOURNAL (2001)
TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins
F Kanai et al.
EMBO JOURNAL (2000)
Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans - A quantitative study
A Gastaldelli et al.
DIABETES (2000)
Phosphoenolpyruvate carboxykinase is necessary for the integration of hepatic energy metabolism
P She et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
分享论文
